32(top 20%)
PR articles
4.3K(top 5%)
PR citations
27(top 5%)
PR h-index
28(top 5%)
h-index
35
documents
5.2K
doc citations
1.3K
citing journals
100
times ranked

Publications

32 peer-reviewed articles • 4,528 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged children
PLoS Neglected Tropical Diseases, 2020, 14, e0008866
1.921Citations (PDF)
2Targeting Peripheral CB1 Receptors Reduces Ethanol Intake via a Gut-Brain Axis
Cell Metabolism, 2019, 29, 1320-1333.e8
20.963Citations (PDF)
3Plasma metabolome analysis of patients with major depressive disorder
Psychiatry and Clinical Neurosciences, 2018, 72, 349-361
2.563Citations (PDF)
4Mice lacking GPR3 receptors display late-onset obese phenotype due to impaired thermogenic function in brown adipose tissue
Scientific Reports, 2015, 5,
2.748Citations (PDF)
5Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences
Cell and Bioscience, 2015, 5,
3.539Citations (PDF)
6Dietary Linoleic Acid Elevates Endogenous 2‐AG and Anandamide and Induces Obesity
Obesity, 2012, 20, 1984-1994
2.9223Citations (PDF)
7Inhibitor of Fatty Acid Amide Hydrolase Normalizes Cardiovascular Function in Hypertension without Adverse Metabolic Effects
Chemistry and Biology, 2010, 17, 1256-1266
4.794Citations (PDF)
8Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-γ
Journal of Biological Chemistry, 2010, 285, 19002-19011
1.395Citations (PDF)
9Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Journal of Clinical Investigation, 2010, 120, 2953-2966
6.8436Citations (PDF)
10PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acidω‐Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease
PPAR Research, 2009, 2009,
0.7140Citations (PDF)
11The Endogenous Brain Constituent N-Arachidonoyl l-Serine Is an Activator of Large Conductance Ca2+-Activated K+ Channels
Journal of Pharmacology and Experimental Therapeutics, 2009, 328, 351-361
2.343Citations (PDF)
12Cell Type–Dependent Pro- and Anti-Inflammatory Role of Signal Transducer and Activator of Transcription 3 in Alcoholic Liver Injury
Gastroenterology, 2008, 134, 1148-1158
0.9192Citations (PDF)
13Paracrine Activation of Hepatic CB1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver
Cell Metabolism, 2008, 7, 227-235
20.9294Citations (PDF)
14Endocannabinoids and the Control of Energy Homeostasis
Journal of Biological Chemistry, 2008, 283, 33021-33025
1.395Citations (PDF)
15Endocannabinoids and Liver Disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis
American Journal of Physiology - Renal Physiology, 2008, 294, G1101-G1104
1.852Citations (PDF)
16Sustained Weight Loss After Roux-en-Y Gastric Bypass Is Characterized by Down Regulation of Endocannabinoids and Mitochondrial Function
Annals of Surgery, 2008, 247, 779-790
3.449Citations (PDF)
17Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
Journal of Clinical Investigation, 2008, 118, 3160-3169
6.8428Citations (PDF)
18Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis
Journal of Leukocyte Biology, 2007, 82, 1382-1389
1.7135Citations (PDF)
19Endocannabinoid system in cancer cachexia
Current Opinion in Clinical Nutrition and Metabolic Care, 2007, 10, 443-448
1.719Citations (PDF)
20Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury
FASEB Journal, 2007, 21, 1788-1800
2.3230Citations (PDF)
21A biosynthetic pathway for anandamide
Proceedings of the National Academy of Sciences of the United States of America, 2006, 103, 13345-13350
5.3443Citations (PDF)
22The role of the endocannabinoid system in the control of energy homeostasis
International Journal of Obesity, 2006, 30, S33-S38
2.786Citations (PDF)
23Glutathione‐S‐transferase expression in the brain: possible role in ethanol preference and longevity
FASEB Journal, 2006, 20, 1826-1835
2.342Citations (PDF)
24Evidence for novel cannabinoid receptors
2005, 106, 133-145
358Citations (PDF)
25Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase
American Journal of Physiology - Heart and Circulatory Physiology, 2005, 289, H533-H541
2.275Citations (PDF)
26Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
Journal of Clinical Investigation, 2005, 115, 1298-1305
6.8889Citations (PDF)
27Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
Journal of Clinical Investigation, 2005, 115, 1298-1305
6.8516Citations (PDF)
28Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension
Circulation, 2004, 110, 1996-2002
13.1327Citations (PDF)
29Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patients
Neurology, 2001, 56, 490-496
0.758Citations (PDF)
30Influence of Grip Strength on Metacarpal Bone Mineral Density in Postmenopausal Japanese Women: A Cross-Sectional Study
Calcified Tissue International, 1999, 64, 263-266
1.737Citations (PDF)
31Risk Factors for breast cancer among japanese women: A case-control study in Ibaraki, Japan
Breast Cancer, 1998, 5, 351-358
1.87Citations (PDF)
32Timing of Menopause, Reproductive Years, and Bone Mineral Density: A Cross-Sectional Study of Postmenopausal Japanese Women
American Journal of Epidemiology, 1998, 148, 1055-1061
2.446Citations (PDF)